{
    "Company Name": "Anthem Biosciences IPO",
    "IPO_Date": "July 14, 2025 to July 16, 2025",
    "Listing_Date": "July 21, 2025",
    "Face_Value": "2 per share",
    "Issue_Price": "570 per share",
    "Lot_Size": "26 Shares",
    "Sale_Type": "Offer For Sale",
    "Total_Issue_Size": "5,95,75,319 shares (aggregating up to 3,395.79 Cr)",
    "Employee_Discount": "50.00 ",
    "Issue_Type": "Bookbuilding IPO",
    "Listing_At": "BSE, NSE",
    "Share_Holding_Pre_Issue": "76.87%",
    "Share_Holding_Post_Issue": "74.68%",
    "\n\n\nQIB_Shares_Offered": "NA",
    "_Anchor_Investor_Shares_Offered": "NA",
    "_QIB_(Ex._Anchor)_Shares_Offered": "NA",
    "\n\n\nNII_(HNI)_Shares_Offered": "NA",
    "_bNII_>_10L": "16,323",
    "_sNII_<_10L": "8,161",
    "Retail_Shares_Offered": "7,99,839",
    "Employee_Shares_Offered": "NA",
    "Total_Shares_Offered": "",
    "Bid_Date": "July 11, 2025",
    "Shares_Offered": "1,78,24,999",
    "Anchor_Portion_Size_(In_Cr.)": "1,016.02",
    "Anchor_lock-in_period_end_date_for_50%_shares_(30_Days)": "August 15, 2025",
    "Anchor_lock-in_period_end_date_for_remaining_shares_(90_Days)": "October 14, 2025",
    "IPO_Open_Date": "Mon, Jul 14, 2025",
    "IPO_Close_Date": "Wed, Jul 16, 2025",
    "Tentative_Allotment": "Thu, Jul 17, 2025",
    "Initiation_of_Refunds": "Fri, Jul 18, 2025",
    "Credit_of_Shares_to_Demat": "Fri, Jul 18, 2025",
    "Tentative_Listing_Date": "Mon, Jul 21, 2025",
    "Cut-off_time_for_UPI_mandate_confirmation": "5 PM on July 16, 2025",
    "Retail_(Min)": "14,820",
    "Retail_(Max)": "1,92,660",
    "S-HNI_(Min)": "2,07,480",
    "S-HNI_(Max)": "9,92,940",
    "B-HNI_(Min)": "10,07,760",
    "ROE": "20.82%",
    "ROCE": "26.88%",
    "Debt/Equity": "0.05",
    "RoNW": "20.82%",
    "PAT_Margin": "23.38%",
    "EBITDA_Margin": "36.81%",
    "Price_to_Book_Value": "13.23",
    "EPS_(Rs)": "8.07",
    "P/E_(x)": "70.62",
    "Brokers": "0",
    "Members": "0"
}